Motor, Non-motor and Genetic Determinants of Progression in Parkinson's Disease: A Mexican Multicenter Cohort Study
NCT ID: NCT01865877
Last Updated: 2017-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
550 participants
OBSERVATIONAL
2012-08-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A large sample of Mexican subjects with Parkinson's disease attending several referral centers will be included.
Data collected will include disease severity and motor scales, non-motor scales as well as genotyping for monogenic forms of the disease.
Assessments will be performed every 6 months for two years.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parkinson's Disease Progression Study
NCT06219629
Research of Biomarkers in Parkinson Disease
NCT00465790
mHealth Technology in People With Parkinson's Disease
NCT05829915
miRNAs Profiling in Parkinson's Disease
NCT03466723
Parkinson's Foundation Surveys
NCT05066763
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recruitment will be competitive. Data collected includes age, gender, motor phenotype, age at onset, age at diagnosis, smoking history, family history, antiparkinsonic treatment, other treatments and a complete neurological evaluation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PD Cohort
Subjects diagnosed with Parkinson's disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any gender
* Any Hoehn and Yahr stage
* Written informed consent
Exclusion Criteria
* Subjects with atypical or secondary parkinsonism
20 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Council of Science and Technology, Mexico
OTHER
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amin Cervantes-Arriaga
MD, MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amin Cervantes-Arriaga, MD,MSc
Role: PRINCIPAL_INVESTIGATOR
Instituto Nacional de Neurología y Neurocirugía
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Civil de Guadalajara
Guadalajara, Jalisco, Mexico
Hospital General de México
Mexico City, Mexico City, Mexico
Instituto Nacional de Neurología y Neurocirugía
Mexico City, Mexico City, Mexico
Hospital Universitario
Monterrey, Nuevo León, Mexico
Hospital Universitario
San Luis Potosí City, San Luis Potosí, Mexico
Hospital Regional #1
Mérida, Yucatán, Mexico
Hospital General de Zacatecas
Zacatecas City, Zacatecas, Mexico
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cervantes-Arriaga A, Rodriguez-Violante M, Lopez-Ruiz M, Estrada-Bellmann I, Zuniga-Ramirez C, Otero-Cerdeira E, Camacho-Ordonez A, Gonzalez-Latapi P, Morales-Briceno H, Martinez-Ramirez D. [Profile characterization of Parkinson's disease in Mexico: ReMePARK study]. Gac Med Mex. 2013 Sep-Oct;149(5):497-501. Spanish.
Cervantes Arriaga A, Rodriguez Violante M, Camacho Ordonez A, Gonzalez Latapi P, Lopez Ruiz M, Estrada Bellmann I, Zuniga Ramirez C, Otero Cerdeira E. [Time from motor symptoms onset to diagnosis of Parkinson's disease in Mexico]. Gac Med Mex. 2014 Dec;150 Suppl 2:242-7. Spanish.
Related Links
Access external resources that provide additional context or updates about the study.
Instituto Nacional de Neurología y Neurocirugía
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
182133
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
INNN 35/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.